Sign inJoin waitlistJoin the waitlist

Paul Harari

Chair of the Department of Human Oncology · University of Wisconsin School of Medicine and Public Health

Credentials: · · · ·

History

Department of Human Oncology · University of Wisconsin School of Medicine and Public Health
Present
Dept. of Human Oncology Department · University of Florida College of Medicine
Present
University of Wisconsin School of Medicine and Public Health
Present

Radiation Oncology
University of Arizona
1985–1989
Preliminary Internal Medicine
University of California Davis Health
1984–1985
University of Virginia School of Medicine
1980–1984
Tufts University, Biology
1976–1980

Research

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
New England Journal of Medicine · 2006 · 3,932 citations
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and…
The Lancet Oncology · 2010 · 1,461 citations
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
The Lancet · 2019 · 1,066 citations

Gregory Hartig
37 papers
Randall Kimple
35 papers
Matthew Witek
19 papers
Aaron Wieland
18 papers
Justine Bruce
16 papers · 7 as a resident
Adam Burr
15 papers · 4 as a resident
MR
Mark Ritter
13 papers
Zachary Morris
13 papers · 6 as a resident
Adam Garden
12 papers
Andrew Baschnagel
12 papers
Grace Blitzer
12 papers · 9 as a resident
Michael Bassetti
11 papers · 5 as a resident

Grants

Head and Neck Cancer SPORE at the University of Wisconsin
National Cancer Institute · P50
Contact PI · $10.4M · University of Wisconsin-Madison
2016–2027
Head and Neck Cancer SPORE at the University of Wisconsin
National Institute of Dental and Craniofacial Research · P50
Contact PI · $10.8M · University of Wisconsin-Madison
2016–2022
EGFR/Radiation Response and Resistance Interactions
National Cancer Institute · R01
Contact PI · $1.3M · University of Wisconsin-Madison
2006–2012
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $5.1K · University of Wisconsin-Madison
2005–2007

Clinical trials

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
Principal investigator · Suspended · Phase 2, Phase 3
NRG Oncology
2022–2027
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
Principal investigator · Terminated
University of Wisconsin, Madison
2017–2019
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Principal investigator · Suspended · Phase 2, Phase 3
National Cancer Institute (NCI)
2013–2027
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Principal investigator · Completed · Phase 2
Radiation Therapy Oncology Group
2004–2016